Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FS33D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,103
Award facts
- Contract value 100% obligated
- $10,103.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $10,103.12 delivery order to Amerisourcebergen Drug Corp on March 20, 2026, for 300 mg/2 mL Dupixent syringes under firm fixed-price terms, with ultimate completion by March 23, 2026.
Place of performance is Conshohocken, PA. The order was issued under no set-aside.
Quick answers
Who was awarded contract SPE2DR26FS33D?
SPE2DR26FS33D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 20, 2026.
How much is contract SPE2DR26FS33D worth?
The government has obligated $10,103 on SPE2DR26FS33D.
Is contract SPE2DR26FS33D an order under another contract?
Yes. SPE2DR26FS33D is a delivery order under SPE2DR25D2204, an indefinite delivery contract.
Was contract SPE2DR26FS33D competed?
The extent of competition for SPE2DR26FS33D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award